Postmenopausal HRT and CHD: clinical implications of recent randomized trial res

Article

Results of the HERS, ERA, and WHI trials suggest a conservative approach to use of HRT in women with evidence of CHD. Dose and duration of therapy may be key to the risk-benefit equation.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Haluk Damgacioglu, PhD, discusses cervical cancer's link to anal cancer risk | Image Credit: cadsci.com.
Natalia Llarena, MD, discusses rising fertility anxiety in Gen Z | Image Credit: havingbabies.com.
Uma Mahadevan, MD, highlights new guidelines for managing IBD | Image Credit: ucsfhealth.org.
© 2025 MJH Life Sciences

All rights reserved.